Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Scholar Rock Holding Corp (NQ: SRRK )

12.18 -0.48 (-3.79%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 214,218
Open 12.54
Bid (Size) 12.15 (4)
Ask (Size) 12.18 (4)
Prev. Close 12.66
Today's Range 12.00 - 12.69
52wk Range 4.325 - 21.17
Shares Outstanding 51,663,391
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Goldman Sachs, New Oriental Education & Technology And Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded lower, with the Dow Jones dropping around 300 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
TSMC, CommScope Holding And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga

Performance

YTD
+27.14%
+27.14%
1 Month
+34.59%
+34.59%
3 Month
+24.80%
+24.80%
6 Month
+93.95%
+93.95%
1 Year
-31.61%
-31.61%

More News

Read More
Insiders Buying Heska, B. Riley Financial And 2 Other Stocks
Via Benzinga
Scholar Rock Provides Corporate Update and Highlights Priorities for 2023
From Scholar Rock
Via Business Wire
Analyst Builds Bullish Case For This Neuromuscular Company, Sees 200% Upside
Via Benzinga
Scholar Rock to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Scholar Rock
Via Business Wire
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Salesforce To $225? Plus Mizuho Predicts $135 For VMware
Via Benzinga
Scholar Rock Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire
Scholar Rock Reports Third Quarter 2022 Financial Results and Highlights Business Progress
From Scholar Rock
Via Business Wire
Recent Phase 1 DRAGON Data Show SRK-181 Continues to be Well Tolerated with Early Indications of Efficacy
From Scholar Rock
Via Business Wire
Scholar Rock Appoints Jing L. Marantz, M.D., Ph.D., M.B.A., as Chief Medical Officer
From Scholar Rock
Via Business Wire
Scholar Rock to Participate in Upcoming Investor Conferences
From Scholar Rock
Via Business Wire
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Apple, Intel, And Some Other Big Stocks Moving Higher On Friday
Via Benzinga
Over $1 Million Bet On Scholar Rock Holding? 3 Stocks Insiders Are Buying
Via Benzinga
New Phase 2 TOPAZ Trial Data Indicate Positive Trends in Quality-of-Life Measures Over 24 Months with Apitegromab for Nonambulatory Patients with Types 2 and 3 SMA
From Scholar Rock
Via Business Wire
Scholar Rock to Present Data from the Phase 1 DRAGON trial at the SITC 37th Annual Meeting
From Scholar Rock
Via Business Wire
Scholar Rock to Present New 24-Month Data from Phase 2 TOPAZ Study at Two International Conferences: World Muscle Society Congress and International Scientific Congress on Spinal Muscular Atrophy
From Scholar Rock
Via Business Wire
Scholar Rock Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
Via Benzinga
Scholar Rock Appoints Jay Backstrom, M.D., M.P.H., to be its Next Chief Executive Officer
From Scholar Rock
Via Business Wire
Expert Ratings for Scholar Rock Holding
Via Benzinga
Scholar Rock to Present at Upcoming ACCP Annual Meeting and World CB & CDx Summit
From Scholar Rock
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.